Rady Children’s Institute for Genomic Medicine (RCIGM®) has announced a groundbreaking international partnership with Sidra Medicine, a leading specialty healthcare organization serving women, children, and young people in the State of Qatar. This collaboration marks a significant milestone as Sidra Medicine becomes the first international site of the BeginNGS (pronounced “beginnings”) genome-based newborn screening program, […]
Sidra Medicine, a member of Qatar Foundation and Rady Children’s Institute for Genomic Medicine (RCIGM) have signed an agreement to collaborate on implementing RCIGM’s genome-based newborn screening research program, BeginNGS (pronounced ‘beginnings’). Sidra Medicine is the first international site to join the BeginNGS Consortium, which will help the healthcare organization to advance the detection of […]
NEW YORK – Rady Children’s Institute for Genomic Medicine (RCIGM) said Tuesday that it has inked a partnership with Sidra Medicine in Qatar to implement the BeginNGS genome-based newborn screening program in the region.
Prof. Stephen Francis Kingsmore talks with the Journal of Translational Genetics and Genomics about Rady Children’s groundbreaking work in rapid whole genome sequencing.
In early 2023, a year after my son was diagnosed with Prader-Willi syndrome (PWS), I began experimenting with newly emerging artificial intelligence (AI) tools to support our family’s care journey. They showed promise but offered little practical help at the time. That changed dramatically last year, when large language models (LLMs) and other AI services […]
Rady Children’s Institute for Genomic Medicine in San Diego proved a game-changer in putting together the pieces. “Evan’s specialists were all based in Los Angeles, but in terms of somebody who was able to oversee such a complex situation, it was Rady’s that led the charge on that,” Scharf says. “They worked in collaboration with the Undiagnosed […]
Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) in San Diego have successfully applied long-read genome sequencing to reveal the genetic underpinnings of complex psychiatric conditions in a 17-year-old patient, showcasing the potential of this advanced technology for clinical diagnosis and future gene therapies.
Dr. Stephen F. Kingsmore, President and CEO of Rady Children’s Institute for Genomic Medicine, discusses how rapid whole genome sequencing helped diagnose a rare genetic condition that caused baby Dakota’s kidneys to fail—leading to lifesaving treatment and a path forward for her family.
Growing evidence shows that genetic testing can inform schizophrenia management by identifying rare genetic variants that may influence treatment and outcomes. Dr. Aaron Besterman, a Health Sciences Associate Clinical Professor at USCD, explores the newest technological advancements in schizophrenia care.
While using genetics to inform schizophrenia management has become a promising new method, it also comes with several ethical challenges. Dr. Aaron Besterman, a Health Sciences Associate Clinical Professor at UC San Diego, explains how limited research and potential risks can complicate how we leverage these genetic technologies.